JGUA
ELAN icon

John G. Ullman & Associates’s Elanco Animal Health ELAN Stock Holding History

John G. Ullman & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,500
Closed -$164K – 179
2023
Q1 		$164K Buy
17,500
+5,000
+40% +$59K 0.03% 172
2022
Q4 		$153K Buy
+12,500
New +$156K 0.02% 166
2022
Q3 		– Sell
-185,250
Closed -$3.64M – 158
2022
Q2 		$3.64M Sell
185,250
-28,650
-13% -$678K 0.58% 45
2022
Q1 		$5.58M Sell
213,900
-172,375
-45% -$4.59M 0.77% 39
2021
Q4 		$11M Sell
386,275
-19,990
-5% -$622K 1.51% 23
2021
Q3 		$13M Sell
406,265
-17,460
-4% -$586K 1.76% 19
2021
Q2 		$14.7M Buy
423,725
+3,275
+0.8% +$108K 1.92% 20
2021
Q1 		$12.4M Buy
420,450
+149,350
+55% +$4.59M 1.66% 23
2020
Q4 		$8.31M Buy
271,100
+54,200
+25% +$1.65M 1.29% 28
2020
Q3 		$6.06M Buy
216,900
+56,700
+35% +$1.44M 1.25% 28
2020
Q2 		$3.44M Buy
160,200
+5,000
+3% +$110K 0.84% 37
2020
Q1 		$3.48M Sell
155,200
-1,300
-0.8% -$35.6K 0.92% 33
2019
Q4 		$4.61M Buy
156,500
+65,700
+72% +$1.79M 0.79% 41
2019
Q3 		$2.41M Buy
+90,800
New +$2.72M 0.44% 56

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

John G. Ullman & Associates's ELAN Position: Q2 2023 in Review

John G. Ullman & Associates sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 17,500 shares — an estimated $164K sold.

John G. Ullman & Associates first reported a position in ELAN in Q3 2019 and held it in 14 quarters. The position peaked at $14.7M in Q2 2021. 351 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • John G. Ullman & Associates reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • John G. Ullman & Associates sold 17,500 Elanco Animal Health shares in Q2 2023, an estimated $164K.
  • John G. Ullman & Associates first reported a position in Elanco Animal Health in Q3 2019 and held it in 14 quarters.
  • John G. Ullman & Associates's Elanco Animal Health position peaked at $14.7M in Q2 2021.
  • 351 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on John G. Ullman & Associates's 13F filing for Q2 2023, filed 21 Aug 2023.